| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,110,200 | 1,156,800 | 1,010,300 | 1,429,300 | | Cost of Revenue | 45,400 | 52,300 | 65,400 | 171,100 | | | Gross Profit | 1,064,800 | 1,104,500 | 944,900 | 1,258,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 599,200 | 502,700 | 593,500 | 509,100 | | Non Recurring |
-
|
-
|
-
| 46,100 | | Others | 157,600 | 77,100 | 55,000 | 116,300 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 308,000 | 524,700 | 296,400 | 586,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 308,000 | 524,700 | 296,400 | 586,700 | | Interest Expense | 49,500 | 52,200 | 51,300 | 64,400 | | Income Before Tax | 258,500 | 472,500 | 245,100 | 522,300 | | Income Tax Expense | 70,600 | 158,300 | 83,300 | 180,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 187,900 | 314,200 | 161,800 | 342,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 187,900 | 314,200 | 161,800 | 342,300 | | Preferred Stock And Other Adjustments | (111,100) | 23,000 | (23,000) | (12,000) | | | Net Income Applicable To Common Shares | $76,800 | $337,200 | $138,800 | $330,300 |
|
1.48% Nasdaq 
Income Statement
